US EditionUS striker Balogun's return to fitness boosts Monaco's Champions League hopes
- United States forward Folarin Balogun returned to the starting lineup for the entirety of Monaco's 3-1 victory at Saint-Etienne last weekend, marking his first full appearance following shoulder surgery in December.
- Balogun suffered a shoulder injury after a hit against Marseille, which aggravated his condition and led him to opt for surgery.
- After returning to action with Monaco's reserve team in March and making five substitute appearances, Balogun earned a starting spot last week and scored his first league goal of the year.
- Balogun expressed that completing a full match significantly boosted both his physical condition and self-assurance, noting he initially felt some nervousness but has since gained full confidence.
- Monaco's win kept them in contention for a Champions League place, with two rounds left and Monaco one point behind second-placed Marseille in Ligue 1.
14 Articles
14 Articles
NiagaraFallsReview.ca
The Toronto StarUS striker Balogun’s return to fitness boosts Monaco’s Champions League hopes
MONACO (AP) — Folarin Balogun is back in form and that's excellent news for Monaco as the race for Champions League places draws to a close in Ligue 1.
Idaho Press
US striker Balogun's return to fitness boosts Monaco's Champions League hopes
MONACO (AP) — Folarin Balogun is back in form and that's excellent news for Monaco as the race for Champions League places draws to a close in Ligue 1.
AS Monaco announce extension with nutrition company Zumub - Inside World Football
May 8 – AS Monaco have announced the extension of their partnership with Portuguese sports nutrition company Zumub, which will remain the club’s official nutrition supplier through to the end of the 2025/26 season. The renewed agreement continues a relationship that began in 2021 and sees Zumub play a key role in the physical preparation and recovery of Monaco’s first-team players. The brand, which claims to offer Europe’s largest catalogue of s…
Coverage Details
Bias Distribution
- 45% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
